ALIT Q2 2026 - Preliminary Earnings Alert

Event: Quartr Q2 2026 event Retrieved: 2026-08-04T21:55:00Z Comparison mode: maximal Scorecard contract: v1 Source status: release=available | financials=release document and earnings presentation only | transcript=available and complete, not read for this stage

Consensus scorecard

Reported results and guidance

All share and per-share figures reflect the 1-for-20 reverse stock split effective 30 June 2026, retroactively applied to all periods presented.

2026 outlook issued with the release:

• Scorecard recap: revenue beat consensus by 2.8% ($511m vs. $497.0m) and adjusted diluted EPS from continuing operations beat by 20.2% ($0.91 vs. $0.757).
• The CEO states results "once again exceeded expectations for both total revenue and adjusted EBITDA" and that the business "remained highly cash generative."
• The CEO also states the back half of the year "will be impacted by the commercial execution experienced in 2025 and seasonally higher expenses in Q3."
• Recurring revenue was 92.2% of total revenue. Liquidity at 30 June 2026 was more than $545m: $215m of cash and equivalents plus $330m available on the revolver.

Key bullish aspects

• Both scorecard metrics beat: revenue of $511m came in $14m above consensus and adjusted diluted EPS of $0.91 came in 20.2% above the $0.757 estimate.
• Project revenue grew 11.1% to $40m in the quarter and 18.8% to $76m for the six months, the only revenue line growing, and the company attributes part of the revenue decline offset to it.
• Selling, general and administrative expense fell $21m year over year, which the company attributes primarily to lower severance and other restructuring costs; restructuring charges in the adjusted EBITDA bridge fell to $16m from $36m.
• The prior-year quarter carried a $983m non-cash goodwill impairment on the Health Solutions reporting unit that did not repeat, so the loss before taxes narrowed to $(19)m from $(1,076)m.
• Cash generation held up despite the earnings decline: six-month free cash flow of $101m was essentially flat against $102m a year earlier, on $152m of operating cash flow and $51m of capital expenditure.
• The tax receivable agreement liability fell to $443m from $508m at year-end and produced a $46m fair-value gain in the quarter, and the company paid down $136m of TRA obligations in the six months.
• Total debt edged down to $1,996m from $2,005m at year-end, and the company describes itself as preserving capital to maintain flexibility on allocation.
• Recurring revenue at 92.2% of the total supports the company's characterization of benefits administration as non-discretionary and resilient to economic cycles.

Key bearish aspects

• Revenue declined 3.2% year over year to $511m and recurring revenue — 92% of the base — declined 4.3%. The company attributes the change primarily to lower net commercial activity.
• Profitability fell much faster than revenue. Adjusted EBITDA dropped 27.6% to $92m on a 3.2% revenue decline, and adjusted EBITDA margin compressed 610 basis points to 18.0%.
• Gross margin compressed 550 basis points to 27.8% and adjusted gross margin 440 basis points to 34.4%, with cost of services rising 3.7% to $337m against falling revenue.
• Adjusted diluted EPS fell 56.5% year over year to $0.91, and six-month adjusted diluted EPS fell 46.6% to $2.14, so the beat is against a materially reduced bar rather than growth.
• The quarter is still a GAAP loss: $(10)m net loss from continuing operations and $(0.38) diluted EPS.
• The guidance implies further deterioration. The Q3 revenue guide of $469–479m is below the $511m just reported, and the Q3 adjusted EBITDA guide of $55–61m is roughly a third below the $92m just reported.
• Full-year adjusted EBITDA guidance of $400–415m against $196m delivered in the first half requires $204–219m in the second half, which sits above the run rate implied by the Q3 guide and therefore concentrates the year in Q4.
• Cash and equivalents fell to $215m from $273m at year-end while net debt rose to $1,781m from $1,732m, so leverage increased against a falling EBITDA base.
• Management explicitly flags that the second half will be affected by 2025 commercial execution, which points to the revenue decline being a booked-backlog problem rather than a timing one.
• Depreciation and amortization within cost of services rose to $32m from $27m even as revenue fell, and unvested RSU dilution in the adjusted share count rose to 2.15m shares from 0.37m a year earlier.

Key uncertainties

• The company does not disclose in this release how much of the full-year revenue and adjusted EBITDA guidance is already contracted, so the credibility of the Q4-weighted profile the guidance implies cannot be assessed from these documents.
• Prior guidance for Q3 and the full year is not restated in this release or presentation, so whether these ranges represent a raise, a cut, or a reiteration cannot be determined from the Quartr documents for this event.
• "Lower net commercial activity" is not quantified into gross losses versus new sales, and no client retention or bookings figure is given, so the trajectory of the recurring base beyond this quarter is unclear.
• The company describes insourcing critical client service functions that had been outsourced and heavy AI-led modernization investment, but gives no cost, timeline, or expected savings for either, so the margin path is unquantified.
• Forward adjusted EBITDA guidance carries no GAAP equivalent; the company states a reconciliation is not accessible without unreasonable effort, so the implied GAAP result for Q3 and the full year is unknown.
• The $46m gain from remeasuring the tax receivable agreement is a non-cash, non-operating item that reversed a $23m loss a year earlier; a $136m six-month cash payment on the same agreement is a real outflow, and the release does not lay out the remaining payment schedule against the $443m liability.
• Goodwill is only $83m while intangible assets net are $2,433m against $4,268m of total assets, and the prior year's $983m impairment shows how quickly that carrying value can move; the release gives no update on the current impairment assessment.
• The reverse stock split makes prior-period per-share comparisons dependent on retroactive adjustment. The consensus estimate used here is treated as post-split; the provider's own historical actuals for this ticker are stated on the pre-split basis.
• Six-month figures are disclosed for cash flow, but quarterly operating and free cash flow are not broken out, so the quarter's own cash conversion cannot be isolated.
• Leadership turnover is extensive, with a new CEO, CFO, CTO, Chief Legal Officer, Chief HR Officer and Chief Commercial Officer among those named; the transformation depends on that team executing.

Market context

• API Ninjas snapshot: ALIT $17.18 on NYSE, volume 1,059,891, retrieved 2026-08-04T21:44:58Z. The earnings release was published at approximately 2026-08-04T20:12Z and the presentation at approximately 2026-08-04T20:08Z, after the 4:00 p.m. ET close, and the 4:30 p.m. ET earnings call was in progress at the snapshot time. This is a single quote of unstated session basis, not a measured reaction to the release.

Source limitations

• Every actual above comes from the Quartr earnings release document and the Quartr Q2 2026 earnings presentation; Quartr standardized financials for this event are not yet populated.
• API Ninjas supplied no actual or difference fields for this event, so each beat/miss is calculated locally as Quartr actual minus API Ninjas estimate. The API row carried no fiscal year or quarter, so the exact ticker-and-event-date match path was used.
• The scorecard uses adjusted diluted EPS from continuing operations of $0.91 under the headline-adjusted-EPS-first rule. GAAP diluted EPS from continuing operations is $(0.38) and is shown in the results table above.
• Prior-guidance figures are not present in the Quartr documents for this event, so the guidance table shows the new ranges against comparison points drawn from this release rather than against a prior guide.
• Year-over-year percentage changes not printed in the release are calculated from the release's own three-month and six-month columns.
• Quartr marks the transcript for this event as available and complete; it has not been read for this preliminary report. A separate post-call update covers it.

Source links

• Quartr Q2 2026 earnings release
• Quartr release statements of income page
• Quartr release adjusted diluted EPS reconciliation page
• Quartr Q2 2026 earnings presentation